1
|
Chiang FF, Huang SC, Yu PT, Chao TH, Huang YC. Oxidative Stress Induced by Chemotherapy: Evaluation of Glutathione and Its Related Antioxidant Enzyme Dynamics in Patients with Colorectal Cancer. Nutrients 2023; 15:5104. [PMID: 38140363 PMCID: PMC10745799 DOI: 10.3390/nu15245104] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Revised: 12/10/2023] [Accepted: 12/10/2023] [Indexed: 12/24/2023] Open
Abstract
One of the mechanisms of chemotherapy is to increase the oxidative stress of cancer cells, leading to their apoptosis. Glutathione (GSH) and its related antioxidant enzymes might be stimulated to cope with increased oxidative stress during chemotherapy. Here, we studied the fluctuation in oxidative stress and GSH-related antioxidant capacities before tumor resection, after tumor resection, and after resection either with or without chemotherapy in patients with colorectal cancer (CRC). This was a cross-sectional and follow-up design. We followed patients before having tumor resection (pre-resection), one month after tumor resection (post-resection), and after the first scheduled chemotherapy (post-chemo). If patients were required to receive chemotherapy after tumor resection, they were assigned to the chemotherapy group. Eligible patients were scheduled to undergo six to twelve cycles of chemotherapy at 2-week intervals and received single, double, or triple chemotherapeutic drugs as required. Those patients who did not require chemotherapy were assigned to the non-chemotherapy group. Indicators of oxidative stress and GSH-related antioxidant capacities were determined at the above three time points. We found in 48 patients of the chemotherapy group and in 43 patients of the non-chemotherapy group different fluctuations in levels of oxidative stress indicators and GSH-related antioxidant capacities starting from pre-resection, post-resection through the post-chemo period. Both groups showed significantly or slightly increased levels of advanced oxidation protein products (AOPP), GSH, and its related enzymes in tumor tissues compared to adjacent normal tissues. Patients in the chemotherapy group had significantly lower plasma levels of GSH and glutathione disulfide (GSSG), but had significantly higher plasma glutathione peroxidase and glutathione reductase activities than patients in the non-chemotherapy group post-chemo. Plasma levels of malondialdehyde and AOPP were positively or negatively associated with GSH and GSSG levels post-chemo after adjustment for age, sex, and histological grading in patients receiving chemotherapy. These significant associations were, however, not seen in patients without chemotherapy. Patients with CRC may require higher GSH demands to cope with a greater oxidative stress resulting from chemotherapy.
Collapse
Affiliation(s)
- Feng-Fan Chiang
- Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung 40705, Taiwan;
- Department of Food and Nutrition, Providence University, Taichung 43301, Taiwan
| | - Shih-Chien Huang
- Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan; (S.-C.H.); (P.-T.Y.)
- Department of Nutrition, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
| | - Pei-Ting Yu
- Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan; (S.-C.H.); (P.-T.Y.)
| | - Te-Hsin Chao
- Chiayi & Wanqiao Branch, Taichung Veterans General Hospital, Chiayi 60090, Taiwan;
| | - Yi-Chia Huang
- Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan; (S.-C.H.); (P.-T.Y.)
- Department of Nutrition, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
| |
Collapse
|
2
|
Acevedo-León D, Gómez-Abril SÁ, Sanz-García P, Estañ-Capell N, Bañuls C, Sáez G. The role of oxidative stress, tumor and inflammatory markers in colorectal cancer patients: A one-year follow-up study. Redox Biol 2023; 62:102662. [PMID: 36917901 PMCID: PMC10023975 DOI: 10.1016/j.redox.2023.102662] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Revised: 03/03/2023] [Accepted: 03/07/2023] [Indexed: 03/09/2023] Open
Abstract
Oxidative stress (OS) and inflammation are known to play an important role in colorectal cancer (CRC). This study analyzed tumor, inflammatory and OS markers in CRC patients and in a control group. In addition, the evolution of these markers was evaluated after one-year of follow-up treatment. This was a longitudinal and prospective, observational study in 80 CRC patients who were candidates for tumor resection surgery and/or chemo-radiotherapy treatment and a healthy control group (n = 60). Subsequently, catalase (CAT), reduced glutathione (GSH), oxidized glutathione (GSSG) and GSSG/GSH ratio in serum and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) and F2-IsoProstanes (F2-IsoPs) in urine at 1, 6 and 12 months after treatment was analyzed. Tumor markers (CEA and CA 19.9), as well as inflammatory markers-leukocytes, neutrophils, neutrophil/lymphocyte (N/L) index, platelets, fibrinogen, C-reactive protein (CRP), and interleukin 6 (IL6)- were also analyzed. As expected, levels of CEA and CA 19.9 and markers of inflammation, except CRP, were significantly higher in CRC compared to the control group. Regarding OS markers, a decrease in CAT and GSH and an increase in GSSG, GSSG/GSH ratio, 8-oxodG and F2-IsoPs were found in CRC patients compared to healthy controls at baseline. After treatment, an improvement of their inflammation profile was accompanied by a progressive recovery of antioxidant enzyme activities and the decline of oxidative byproducts both in serum and urine. Based on the results obtained, we propose the assay of urinary 8-oxodG and F2-IsoPs, as well as serum CAT, GSH, GSSG as a marker for the evaluation of OS and the clinical follow-up of CRC patients.
Collapse
Affiliation(s)
- Delia Acevedo-León
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017, Valencia, Spain
| | - Segundo Ángel Gómez-Abril
- Servicio de Cirugía General y Aparato Digestivo, Hospital Universitario Dr. Peset-FISABIO, 46017, Valencia, Spain
| | - Pablo Sanz-García
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017, Valencia, Spain
| | - Nuria Estañ-Capell
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017, Valencia, Spain
| | - Celia Bañuls
- Servicio de Endocrinología y Nutrición, Hospital Universitario Dr. Peset-FISABIO, 46017, Valencia, Spain.
| | - Guillermo Sáez
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017, Valencia, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Medicina y Odontotología, Universidad de Valencia, 46010, Valencia, Spain.
| |
Collapse
|
3
|
Janion K, Strzelczyk JK, Walkiewicz KW, Biernacki K, Copija A, Szczepańska E, Nowakowska-Zajdel E. Evaluation of Malondialdehyde Level, Total Oxidant/Antioxidant Status and Oxidative Stress Index in Colorectal Cancer Patients. Metabolites 2022; 12:metabo12111118. [PMID: 36422258 PMCID: PMC9695970 DOI: 10.3390/metabo12111118] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2022] [Revised: 10/21/2022] [Accepted: 11/09/2022] [Indexed: 11/18/2022] Open
Abstract
Oxidative stress may play an important role in colorectal cancer (CRC). The present study included 94 adult patients with CRC (52 men and 42 women) and 26 hospitalized patients (12 men and 14 women) in whom CRC was excluded (control group). During hospitalization, blood serum samples were collected from both groups. Apart from that, anthropometric measurements were taken and other clinical data were analyzed. Serum malondialdehyde (MDA) level, total oxidant status (TOS), total antioxidant status (TAS) and oxidative stress index (OSI) were assayed. Subsequently, the relationship between the analyzed oxidative stress markers and selected clinical characteristics was investigated in both groups. The evaluation of oxidative stress marker values demonstrated that MDA and TAS levels were significantly higher in the control group than the CRC group (p < 0.001 and p = 0.019, respectively), while TOS levels were significantly higher in the CRC group than the control group (p = 0.005). Significantly lower OSI levels were found in the control group than in the CRC group (p < 0.001). Similar results can be observed when performing ROC analysis (receiver operating characteristic curve). Preliminary statistical analysis demonstrated that MDA levels in the study group depend on the location of the primary tumour (p = 0.035). Based on the post hoc Tukey test, a relationship was demonstrated between the MDA level and the left and right side of the colon (p = 0.040). The results may be evidence for a higher level of oxidative stress, including a compromised antioxidative defence system, in patients with CRC.
Collapse
Affiliation(s)
- Karolina Janion
- Department of Nutrition-Related Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland
| | - Joanna Katarzyna Strzelczyk
- Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-808 Zabrze, Poland
| | | | - Krzysztof Biernacki
- Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-808 Zabrze, Poland
| | - Angelika Copija
- Department of Nutrition-Related Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland
- Department of Clinical Oncology, No. 4 Provincial Specialist Hospital in Bytom, 41-902 Bytom, Poland
| | - Elżbieta Szczepańska
- Department of Human Nutrition, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-808 Zabrze, Poland
| | - Ewa Nowakowska-Zajdel
- Department of Nutrition-Related Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland
- Department of Clinical Oncology, No. 4 Provincial Specialist Hospital in Bytom, 41-902 Bytom, Poland
- Correspondence:
| |
Collapse
|
4
|
Chiang FF, Chao TH, Huang SC, Cheng CH, Tseng YY, Huang YC. Cysteine Regulates Oxidative Stress and Glutathione-Related Antioxidative Capacity before and after Colorectal Tumor Resection. Int J Mol Sci 2022; 23:ijms23179581. [PMID: 36076975 PMCID: PMC9455234 DOI: 10.3390/ijms23179581] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Revised: 08/19/2022] [Accepted: 08/22/2022] [Indexed: 11/16/2022] Open
Abstract
Cysteine might scavenge free radicals and is a limiting substrate for the cellular synthesis of glutathione (GSH). We investigated the association of cysteine with oxidative stress and GSH-related antioxidant capacity in colorectal cancer (CRC) patients. Plasma samples were drawn from 66 patients 1 day before (pre-resection) and 4 weeks after resection (post-resection). Tumor and adjacent normal tissues were collected. We measured levels of plasma and tissue cysteine, homocysteine, oxidative stress indicators (malondialdehyde, MDA; advanced oxidation protein products, AOPP), GSH, and antioxidant enzyme activities. After tumor resection, patients had significantly higher levels of plasma cysteine, homocysteine, MDA, AOPP, and GSH-related antioxidant enzyme activities when compared with pre-resection. Levels of cysteine, homocysteine, AOPP and all antioxidant capacity indicators in tumor tissue were significantly higher than those levels in the adjacent normal tissue. Plasma cysteine levels measured at pre-resection were positively associated with MDA levels in the tumor and in the adjacent normal tissues. Cysteine levels in tumor and adjacent normal tissues were significantly associated with tissue levels of homocysteine, almost as indicators of oxidative stress and antioxidant capacities. Cysteine in the circulation was likely utilized to mediate GSH-related antioxidant capacity and further cope with increased oxidative stress in tumor and adjacent normal tissues.
Collapse
Affiliation(s)
- Feng-Fan Chiang
- Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung 40705, Taiwan
- Department of Food and Nutrition, Providence University, Taichung 43301, Taiwan
| | - Te-Hsin Chao
- Chiayi & Wanqiao Branch, Taichung Veterans General Hospital, Chiayi 60090, Taiwan
| | - Shih-Chien Huang
- Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan
- Department of Nutrition, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
- Department of Health Industry Technology Management, Chung Shan Medical University, Taichung 40201, Taiwan
| | - Chien-Hsiang Cheng
- Department of Respiratory Therapy, Taichung Veterans General Hospital, Taichung 40705, Taiwan
| | - Yu-Yao Tseng
- Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan
| | - Yi-Chia Huang
- Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan
- Department of Nutrition, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
- Correspondence:
| |
Collapse
|
5
|
Chabane K, Khene MA, Zaida F, Ainouz L, Giaimis J, Mameri S, Baz A. Subacute and subchronic methomyl exposure induced toxic effects on intestines via oxidative stress in male albino rats: biochemical and histopathological study. Drug Chem Toxicol 2022; 45:523-536. [DOI: 10.1080/01480545.2020.1727496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Kahina Chabane
- Laboratory of Biology and Organism Physiology, University of Sciences and Technology, Houari Boumediene (USTHB), Algiers, Algeria
- Laboratory of Biology and Animal Physiology, ENS Kouba, Algiers, Algeria
| | | | - Faiza Zaida
- Laboratory of Biology and Animal Physiology, ENS Kouba, Algiers, Algeria
| | - Lynda Ainouz
- Laboratory of Biology and Animal Physiology, ENS Kouba, Algiers, Algeria
| | - Jean Giaimis
- UMR Qualisud-Faculty of Pharmacy, University of Montpellier I, Montpellier, France
| | - Saâdia Mameri
- Laboratory of Anatomopathology, Mustapha Bacha Hospital, Algiers, Algeria
| | - Ahsene Baz
- Laboratory of Biology and Animal Physiology, ENS Kouba, Algiers, Algeria
| |
Collapse
|
6
|
López-Mejía A, Ortega-Pérez LG, Magaña-Rodríguez OR, Ayala-Ruiz LA, Piñón-Simental JS, Hernández DG, Rios-Chavez P. Protective effect of Callistemon citrinus on oxidative stress in rats with 1,2-dimethylhydrazine-induced colon cancer. Biomed Pharmacother 2021; 142:112070. [PMID: 34435594 DOI: 10.1016/j.biopha.2021.112070] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Revised: 08/12/2021] [Accepted: 08/17/2021] [Indexed: 12/20/2022] Open
Abstract
Callistemon citrinus has terpenes effective in inducing antioxidant enzymes, an important mechanism involved in cancer chemoprevention. This study investigated the chemopreventive efficacy of herbal preparation of C. citrinus leaves against the oxidative stress produced during the colorectal cancer (CRC) in male Wistar rats. The amelioration of toxicity in a model of CRC induced with 1,2-dimethylhydrazine (DMH) was determined by assessing antioxidant enzymes, phase II enzymes activities and lipid peroxidation (LPO) products after 22 weeks of treatment. C. citrinus was administered at a daily oral dose of 250 mg/kg. The activities in proximal, middle and distal colon, liver, kidney and heart were determined. C. citrinus showed a strong antioxidant activity that correlated with the high content of phenolics and terpenoids. DMH treated animals showed a decrease of the enzymes activity in most tissues and the level of reduced glutathione (GSH). Conversely, the levels of lipid peroxidation products were increased. Macroscopic examination revealed the protective effect of C. citrinus in damaged organs caused by DMH. Moreover, histopathological examination of the liver displayed normal structure in the C. citrinus-treated group, unlike the DMH-treated group. C. citrinus supplementation significantly maintained or increased the antioxidant enzyme activities, whereas lipid peroxidation products levels were reduced to values similar to the level of control group. The ability of C. citrinus to induce the antioxidant system reduced the damage of oxidative stress, which makes this plant a good candidate to be used as a prevention agent in treatment of diseases such as colorectal cancer.
Collapse
Affiliation(s)
- Alejandro López-Mejía
- Facultad de Biología, Universidad Michoacana de San Nicolás de Hidalgo. Cd. Universitaria, C.P 58030 Morelia, Michoacán, México
| | - Luis Gerardo Ortega-Pérez
- Facultad de Biología, Universidad Michoacana de San Nicolás de Hidalgo. Cd. Universitaria, C.P 58030 Morelia, Michoacán, México
| | - Oliver Rafid Magaña-Rodríguez
- Facultad de Biología, Universidad Michoacana de San Nicolás de Hidalgo. Cd. Universitaria, C.P 58030 Morelia, Michoacán, México
| | - Luis Alberto Ayala-Ruiz
- Facultad de Biología, Universidad Michoacana de San Nicolás de Hidalgo. Cd. Universitaria, C.P 58030 Morelia, Michoacán, México
| | - Jonathan Saúl Piñón-Simental
- Facultad de Biología, Universidad Michoacana de San Nicolás de Hidalgo. Cd. Universitaria, C.P 58030 Morelia, Michoacán, México
| | - Daniel Godínez Hernández
- Instituto Químico-Biológicas Universidad Michoacana de San Nicolás de Hidalgo, Edificio B-2, Cd Universitaria, Morelia, Michoacán, México
| | - Patricia Rios-Chavez
- Facultad de Biología, Universidad Michoacana de San Nicolás de Hidalgo. Cd. Universitaria, C.P 58030 Morelia, Michoacán, México.
| |
Collapse
|
7
|
Improvement in Redox Homeostasis after Cytoreductive Surgery in Colorectal Adenocarcinoma. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2021; 2021:8864905. [PMID: 34381561 PMCID: PMC8352694 DOI: 10.1155/2021/8864905] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/23/2020] [Revised: 06/25/2021] [Accepted: 07/05/2021] [Indexed: 02/07/2023]
Abstract
Colorectal cancer (CRC) as one the most common cancer type is associated with oxidative stress. Surgery is the only curative modality for early-stage CRC. The aim of this study was to evaluate the oxidative damage biomarkers as well as enzymatic and nonenzymatic antioxidants in patients with CRC before and after tumor resection and in healthy controls. 60 patients with stage I/II colorectal adenocarcinoma and 43 healthy controls were recruited in this study. We measured plasma levels of oxidative damage biomarkers, including advanced oxidation protein products (AOPP), advanced glycation end products (AGEs), malondialdehyde (MDA), and oxidized low-density lipoprotein (ox-LDL) at baseline and after tumor removal. We also evaluated the plasma activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) as enzymatic antioxidants and the ferric reducing antioxidant power (FRAP) assay for nonenzymatic antioxidant capacity. Patients with CRC had significantly higher AGE, AOPP, MDA, and ox-LDL and also FRAP levels and higher SOD and GPx and lower CAT activity levels compared to healthy controls (p < 0.05). We did not observe any statistically significant correlation between redox biomarkers and the size and stage of the tumor. AGEs (72.49 ± 4.7 vs. 67.93 ± 8.8, p < 0.001), AOPP (137.64 ± 21.9 vs. 119.08 ± 33.1, p < 0.001), MDA (3.56 ± 0.30 vs. 3.05 ± 0.33, p < 0.001), and ox-LDL (19.78 ± 0.97 vs. 16.94 ± 1.02, p < 0.001) concentrations reduced significantly after tumor removal. The largest effect sizes were found in ox-LDL (d = -2.853, 95% CI 2.50-3.19) and MDA (d = -1.617, 95% CI 0.43-0.57). Serum FRAP levels (1097.5 ± 156.7 vs. 1239.3 ± 290, p < 0.001) and CAT (2.34 ± 0.34 vs. 2.63 ± 0.38, p < 0.001), GPx (102.37 ± 6.58 vs. 108.03 ± 6.95, p < 0.001), and SOD (5.13 ± 0.39 vs. 5.53 ± 0.31, p < 0.001) activity levels increased significantly after surgery. The largest effect sizes among antioxidants were seen in SOD (d = 1.135, 95% CI 0.46-0.34) and GPx (d = 0.836, 95% CI 0.35-0.23). This study indicated that patients with colorectal cancer had higher levels of oxidative stress and antioxidant activity compared to healthy controls. After surgical resection of tumor, we observed a substantial improvement in redox homeostasis.
Collapse
|
8
|
Acevedo-León D, Monzó-Beltrán L, Gómez-Abril SÁ, Estañ-Capell N, Camarasa-Lillo N, Pérez-Ebri ML, Escandón-Álvarez J, Alonso-Iglesias E, Santaolaria-Ayora ML, Carbonell-Moncho A, Ventura-Gayete J, Pla L, Martínez-Bisbal MC, Martínez-Máñez R, Bagán-Debón L, Viña-Almunia A, Martínez-Santamaría MA, Ruiz-Luque M, Alonso-Fernández J, Bañuls C, Sáez G. The Effectiveness of Glutathione Redox Status as a Possible Tumor Marker in Colorectal Cancer. Int J Mol Sci 2021; 22:ijms22126183. [PMID: 34201191 PMCID: PMC8226858 DOI: 10.3390/ijms22126183] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Revised: 05/27/2021] [Accepted: 06/02/2021] [Indexed: 12/13/2022] Open
Abstract
The role of oxidative stress (OS) in cancer is a matter of great interest due to the implication of reactive oxygen species (ROS) and their oxidation products in the initiation of tumorigenesis, its progression, and metastatic dissemination. Great efforts have been made to identify the mechanisms of ROS-induced carcinogenesis; however, the validation of OS byproducts as potential tumor markers (TMs) remains to be established. This interventional study included a total of 80 colorectal cancer (CRC) patients and 60 controls. By measuring reduced glutathione (GSH), its oxidized form (GSSG), and the glutathione redox state in terms of the GSSG/GSH ratio in the serum of CRC patients, we identified significant changes as compared to healthy subjects. These findings are compatible with the effectiveness of glutathione as a TM. The thiol redox state showed a significant increase towards oxidation in the CRC group and correlated significantly with both the tumor state and the clinical evolution. The sensitivity and specificity of serum glutathione levels are far above those of the classical TMs CEA and CA19.9. We conclude that the GSSG/GSH ratio is a simple assay which could be validated as a novel clinical TM for the diagnosis and monitoring of CRC.
Collapse
Affiliation(s)
- Delia Acevedo-León
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (D.A.-L.); (N.E.-C.); (M.L.S.-A.); (A.C.-M.); (J.V.-G.); (M.A.M.-S.); (M.R.-L.); (J.A.-F.)
| | - Lidia Monzó-Beltrán
- Departamento de Bioquímica y Biología Molecular, Facultad de Medicina y Odontotología-INCLIVA, Universidad de Valencia, 46010 Valencia, Spain; (L.M.-B.); (E.A.-I.)
| | - Segundo Ángel Gómez-Abril
- Servicio de Cirugía General y Aparato Digestivo, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain;
| | - Nuria Estañ-Capell
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (D.A.-L.); (N.E.-C.); (M.L.S.-A.); (A.C.-M.); (J.V.-G.); (M.A.M.-S.); (M.R.-L.); (J.A.-F.)
| | - Natalia Camarasa-Lillo
- Servicio de Anatomía Patológica, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (N.C.-L.); (M.L.P.-E.); (J.E.-Á.)
| | - Marisa Luisa Pérez-Ebri
- Servicio de Anatomía Patológica, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (N.C.-L.); (M.L.P.-E.); (J.E.-Á.)
| | - Jorge Escandón-Álvarez
- Servicio de Anatomía Patológica, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (N.C.-L.); (M.L.P.-E.); (J.E.-Á.)
| | - Eulalia Alonso-Iglesias
- Departamento de Bioquímica y Biología Molecular, Facultad de Medicina y Odontotología-INCLIVA, Universidad de Valencia, 46010 Valencia, Spain; (L.M.-B.); (E.A.-I.)
| | - Marisa Luisa Santaolaria-Ayora
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (D.A.-L.); (N.E.-C.); (M.L.S.-A.); (A.C.-M.); (J.V.-G.); (M.A.M.-S.); (M.R.-L.); (J.A.-F.)
| | - Araceli Carbonell-Moncho
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (D.A.-L.); (N.E.-C.); (M.L.S.-A.); (A.C.-M.); (J.V.-G.); (M.A.M.-S.); (M.R.-L.); (J.A.-F.)
| | - Josep Ventura-Gayete
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (D.A.-L.); (N.E.-C.); (M.L.S.-A.); (A.C.-M.); (J.V.-G.); (M.A.M.-S.); (M.R.-L.); (J.A.-F.)
| | - Luis Pla
- Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València—Universitat de València, 46022 Valencia, Spain; (L.P.); (M.C.M.-B.); (R.M.-M.)
- CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Maria Carmen Martínez-Bisbal
- Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València—Universitat de València, 46022 Valencia, Spain; (L.P.); (M.C.M.-B.); (R.M.-M.)
- CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
- Unidad Mixta UPV-CIPF de Investigación en Mecanismos de Enfermedades y Nanomedicina, Universitat Politècnica de València, Centro de Investigación Príncipe Felipe, 46012 Valencia, Spain
- Unidad Mixta de Investigación en Nanomedicina y Sensores, Universitat Politècnica de València—Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain
- Departamento de Química, Universitat Politècnica de València, 46022 Valencia, Spain
- Departamento de Química Física, Universitat de València, Burjasot, 46100 Valencia, Spain
| | - Ramón Martínez-Máñez
- Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València—Universitat de València, 46022 Valencia, Spain; (L.P.); (M.C.M.-B.); (R.M.-M.)
- CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
- Unidad Mixta UPV-CIPF de Investigación en Mecanismos de Enfermedades y Nanomedicina, Universitat Politècnica de València, Centro de Investigación Príncipe Felipe, 46012 Valencia, Spain
- Unidad Mixta de Investigación en Nanomedicina y Sensores, Universitat Politècnica de València—Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain
- Departamento de Química, Universitat Politècnica de València, 46022 Valencia, Spain
- Departamento de Química Física, Universitat de València, Burjasot, 46100 Valencia, Spain
| | - Leticia Bagán-Debón
- Departamento de Estomatología, Facultad de Medicina y Odontología-INCLIVA, 46010 Valencia, Spain;
| | - Aurora Viña-Almunia
- Centro de Salud San Isidro, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, Spain;
| | - M. Amparo Martínez-Santamaría
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (D.A.-L.); (N.E.-C.); (M.L.S.-A.); (A.C.-M.); (J.V.-G.); (M.A.M.-S.); (M.R.-L.); (J.A.-F.)
| | - María Ruiz-Luque
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (D.A.-L.); (N.E.-C.); (M.L.S.-A.); (A.C.-M.); (J.V.-G.); (M.A.M.-S.); (M.R.-L.); (J.A.-F.)
| | - Jorge Alonso-Fernández
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (D.A.-L.); (N.E.-C.); (M.L.S.-A.); (A.C.-M.); (J.V.-G.); (M.A.M.-S.); (M.R.-L.); (J.A.-F.)
| | - Celia Bañuls
- Servicio de Endocrinología y Nutrición, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain
- Correspondence: (C.B.); (G.S.); Tel.: +34-96-318-9132 (C.B.); +34-96-386-4160 (G.S.)
| | - Guillermo Sáez
- Servicio de Análisis Clínicos, Hospital Universitario Dr. Peset-FISABIO, 46017 Valencia, Spain; (D.A.-L.); (N.E.-C.); (M.L.S.-A.); (A.C.-M.); (J.V.-G.); (M.A.M.-S.); (M.R.-L.); (J.A.-F.)
- Departamento de Bioquímica y Biología Molecular, Facultad de Medicina y Odontotología-INCLIVA, Universidad de Valencia, 46010 Valencia, Spain; (L.M.-B.); (E.A.-I.)
- Correspondence: (C.B.); (G.S.); Tel.: +34-96-318-9132 (C.B.); +34-96-386-4160 (G.S.)
| |
Collapse
|
9
|
Hristova-Avakumova NG, Minchev VT, Kamenova KV, Todorov LT, Angelov MP, Atanasova LA, Surcheva SK, Nikolov RP. Dihydropyrimidine dehydrogenase level and the redox status in patients with colorectal cancer are prognostic for adverse effects of fluoropyrimidines. BIOTECHNOL BIOTEC EQ 2021. [DOI: 10.1080/13102818.2021.1964380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Affiliation(s)
| | - Velko T. Minchev
- Department of Medical Oncology, Sofiamed University Hospital, Sofia, Bulgaria
| | - Kalina V. Kamenova
- Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University Sofia, Sofia, Bulgaria
| | - Lozan T. Todorov
- Department of Chemistry, Faculty of Pharmacy, Medical University Sofia, Sofia, Bulgaria
| | - Marin P. Angelov
- Department of Medical Oncology, Sofiamed University Hospital, Sofia, Bulgaria
| | - Liliya A. Atanasova
- Department of Medical Physics and Biophysics, Medical Faculty, Medical University Sofia, Sofia, Bulgaria
| | - Slavina K. Surcheva
- Department of Pharmacology and Toxicology Medical Faculty, Medical University Sofia, Sofia, Bulgaria
| | - Rumen P. Nikolov
- Department of Pharmacology and Toxicology Medical Faculty, Medical University Sofia, Sofia, Bulgaria
| |
Collapse
|
10
|
Selected Oxidative Stress Markers in Colorectal Cancer Patients in Relation to Primary Tumor Location-A Preliminary Research. ACTA ACUST UNITED AC 2020; 56:medicina56020047. [PMID: 31972987 PMCID: PMC7073713 DOI: 10.3390/medicina56020047] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2019] [Revised: 01/16/2020] [Accepted: 01/20/2020] [Indexed: 01/07/2023]
Abstract
Background and objectives: Ample evidence indicates that oxidative stress, including complex lipid peroxidation processes, may play a significant role in the pathogenesis of colorectal cancer. The goal of this study was to evaluate selected oxidative stress markers in patients with colorectal cancer depending on some clinical features, with particular attention paid to the location of the primary tumor. Materials and Methods: The study was conducted on a group of 66 patients with colorectal cancer. The study consisted of two stages. The first stage involved the analysis of medical records; the second consisted of determining selected oxidative stress markers by measuring malondialdehyde as well as total oxidant and antioxidant status. Results: Of all patients, 43 (65.15%) had colon cancer, of whom 30 (69.77%) had a tumor on the left side and 13 (30.23%) had a tumor on the right side of the colon. Of all the patients, 23 (34.85%) had rectal cancer. The mean total oxidant and antioxidant status was 809.76 (SD ± 392.65) µmol/L and 253.19 (233.33-310.66) µmol/L, respectively. The mean malondialdehyde serum level was 2478.04 (SD ± 1397.05) ng/mL. The mean malondialdehyde serum concentration in patients with primary tumors located on the right side was higher in a statistically significant way compared with the remaining patients. Conclusions: It was demonstrated that the intensity of lipid peroxidation processes is correlated with the development of colorectal cancer, particularly on the right side. The results should be interpreted rather cautiously due to certain limitations of the study.
Collapse
|